Hired and Retired: Pharma C-suites see new faces
(Image: Getty/Gajus)
While last month saw many pharma executives leaving their positions to head towards smaller biotech companies, this month saw members of the industry climbing the ladder from all different starting points.
Clinigen’s C-suite will have a former pharmacist turned qualified account heading up financial matters, and bio-technology companies like Oxford Genetics will be bolstered by experienced managers.
